Back
Horizon Europe Project LiverTarget gets funded
Horizon Europe Project LiverTarget gets funded
LiverTarget is an international consortium that aims to deliver RNA therapeutics to the liver. The liver plays a central role in several cardiovascular disorders because of its key function in metabolic processes like lipid distribution. Using RNA therapeutics, metabolic pathways can be activated or downregulated to delineate their role in cardiovascular disease. The total grant is worth 6 million euro. For more information: Prof. dr. Raymond Schiffelers, professor of nanomedicine, r.schiffelers@umcutrecht.nl